CY1117369T1 - Vaccine Vaccine Vaccine Containing 30 Common Nucleotide Deletions in the 3'-UTR of Vaccine Vaccines Types 1 and 2 - Google Patents

Vaccine Vaccine Vaccine Containing 30 Common Nucleotide Deletions in the 3'-UTR of Vaccine Vaccines Types 1 and 2

Info

Publication number
CY1117369T1
CY1117369T1 CY20101101176T CY101101176T CY1117369T1 CY 1117369 T1 CY1117369 T1 CY 1117369T1 CY 20101101176 T CY20101101176 T CY 20101101176T CY 101101176 T CY101101176 T CY 101101176T CY 1117369 T1 CY1117369 T1 CY 1117369T1
Authority
CY
Cyprus
Prior art keywords
vaccine
utr
types
vaccines
nucleotide deletions
Prior art date
Application number
CY20101101176T
Other languages
Greek (el)
Inventor
Stephen S Whitehead
Brian R Murphy
Lewis Markoff
Barry Falgout
Joseph Blaney
Kathryn Hanley
Original Assignee
The United States Government As Represented By The Department Of Health And Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03724319A external-priority patent/EP1554301B1/en
Application filed by The United States Government As Represented By The Department Of Health And Human Services filed Critical The United States Government As Represented By The Department Of Health And Human Services
Publication of CY1117369T1 publication Critical patent/CY1117369T1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Η εφεύρεση σχετίζεται με ένα τετρασθενές εμβόλιο για τον ιό του δάγγειου πυρετού που περιέχει μια κοινή 30 νουκλεοτιδίων διαγραφή (Δ30) στην 3'-αμετάφραστη περιοχή του γονιδιώματος των ορότυπων 1, 2, 3 και 4 του ιού του δάγγειου πυρετού, ή αντιγονικό χιμαιρικό ορότυπων 1, 2, 3 και 4 ιού του δάγγειου πυρετού.The invention relates to a quadruplevirus vaccine virus containing a common 30 nucleotide deletion (Δ30) in the 3'-untranslated region of the dengue virus serotype 1, 2, 3 and 4 genome, or antigenic chimeric 1, 2, 3 and 4 dengue virus.

CY20101101176T 2002-05-03 2010-12-22 Vaccine Vaccine Vaccine Containing 30 Common Nucleotide Deletions in the 3'-UTR of Vaccine Vaccines Types 1 and 2 CY1117369T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37786002A 2002-05-03 2002-05-03
US43650002A 2002-12-23 2002-12-23
EP03724319A EP1554301B1 (en) 2002-05-03 2003-04-25 Dengue vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1 and 2.

Publications (1)

Publication Number Publication Date
CY1117369T1 true CY1117369T1 (en) 2017-04-26

Family

ID=58606659

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101101176T CY1117369T1 (en) 2002-05-03 2010-12-22 Vaccine Vaccine Vaccine Containing 30 Common Nucleotide Deletions in the 3'-UTR of Vaccine Vaccines Types 1 and 2

Country Status (1)

Country Link
CY (1) CY1117369T1 (en)

Similar Documents

Publication Publication Date Title
EP1554301A4 (en) Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
UA85536C2 (en) Viral antigens
ES2153223T3 (en) CHIMERIC FLAVIVIRUS AND / OR RESTRICTED GROWTH FLAVIVIRUS.
ATE297757T1 (en) CHIMERIC VACCINES AGAINST FLAVIVIRUS
DE60226911D1 (en) Development of a vaccine for the prevention of filovirus infections in primates
ATE451119T1 (en) SUBUNITY VACCINE AGAINST RESPIRATORY SYNZYTIAL VIRUS
DE122011100037I1 (en) Recombinant influenza viruses for vaccine production and gene therapy.
EA200801756A1 (en) ANTIGRIPOPOSIC VACCINES CONTAINING HEMAGGLUTININ AND PROTEINS OF MATRIX
ATE485056T1 (en) IMPROVED VACCINES
DE60330708D1 (en) VACCINE AGAINST WEST NILE VIRUS
DK1425404T3 (en) Vaccinia MVA-E3L Mutants and Their Use
NO983946L (en) Parapox viruses containing foreign DNA, preparation and use thereof in vaccines
CY1106570T1 (en) STABLE, ATTENUATED MUTANT FORMS OF RABIES VIRUS AND LIVE VACCINES THEREOF
CY1107560T1 (en) LIVING DESTROYED BACTERIA FOR USE IN THE VACCINE
DE60040219D1 (en) INFECTIOUS CDNA CLONING OF GB VIRUS B AND ITS USES
CY1117369T1 (en) Vaccine Vaccine Vaccine Containing 30 Common Nucleotide Deletions in the 3'-UTR of Vaccine Vaccines Types 1 and 2
ATE427119T1 (en) RECOMBINANT RABIES VACCINE AND METHOD FOR THE PRODUCTION AND USE THEREOF
YU36698A (en) Parapoxviruses containing foreign dna, their production and their use in vaccines
DE69922804D1 (en) USE OF POLYMERS OF HYALURONIC ACID FOR THE MUCOSAL RELEASE OF VACCINES AND ADJUVANTIES
DE60330795D1 (en) VACCINE AGAINST WEST NILE VIRUS
BR9508645A (en) Feline Infectious Peritonitis Vaccine
HUP0103871A2 (en) Recombinent celo virus and celo virus dna
CY1107371T1 (en) INCREASE OF THYMOSYNUM IN GENETIC IMMUNIZATION
CY1109268T1 (en) NEISSERIA Genome Sequences and Methods for Their Use
MY145463A (en) Flavivirus ns1 subunit vaccine